Corteva, Inc. $CTVA Shares Bought by Hsbc Holdings PLC

Hsbc Holdings PLC raised its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 16.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,479,864 shares of the company’s stock after buying an additional 211,386 shares during the quarter. Hsbc Holdings PLC owned about 0.22% of Corteva worth $125,360,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. William B. Walkup & Associates Inc. grew its holdings in Corteva by 2.9% in the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after buying an additional 126 shares in the last quarter. Wilkerson Advisory Group LLC boosted its position in shares of Corteva by 6.7% during the 1st quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after acquiring an additional 133 shares during the last quarter. AdvisorNet Financial Inc grew its holdings in shares of Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock valued at $477,000 after purchasing an additional 135 shares during the period. First Horizon Corp increased its position in Corteva by 9.2% during the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock worth $134,000 after purchasing an additional 135 shares during the last quarter. Finally, Aviance Capital Partners LLC raised its stake in Corteva by 1.3% during the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock worth $922,000 after purchasing an additional 137 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Trading Up 0.4%

NYSE CTVA opened at $83.18 on Wednesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a market cap of $55.50 billion, a price-to-earnings ratio of 55.09, a PEG ratio of 2.54 and a beta of 0.57. The firm has a 50 day simple moving average of $82.39 and a 200-day simple moving average of $80.37. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period last year, the firm earned $2.20 earnings per share. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is 47.68%.

Analysts Set New Price Targets

Several research firms have recently weighed in on CTVA. Citigroup increased their price target on shares of Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Rothschild & Co Redburn upped their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Weiss Ratings cut shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Finally, Barclays upped their price target on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.